387086006: Levodopa (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor agonist mechanism of action (substance)\Substance with dopamine receptor agonist mechanism of action\Dihydroxyphenylalanine\Levodopa

\Drug or medicament\Central nervous system agent\Antiparkinsonian agent\Dihydroxyphenylalanine\Levodopa

\Substance categorized by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Levodopa

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Levodopa

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

1461264012 Levodopa (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

1481200014 Levodopa en Synonym Active Entire term case insensitive SNOMED CT core module

1491864012 L-3-hydroxytyrosine en Synonym Active Entire term case sensitive SNOMED CT core module

3766620018 L-dopa en Synonym Active Entire term case sensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Levodopa	Is a	Dopamine agent	false	Inferred relationship	Existential restriction modifier
Levodopa	Is a	Dihydroxyphenylalanine	true	Inferred relationship	Existential restriction modifier
Levodopa	Has disposition	Dopamine receptor agonist	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)	Has active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	2
Product containing only levodopa in oral dose form (medicinal product form)	Has active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing only carbidopa and levodopa in enteral dose form (medicinal product form)	Has active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	False	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	False	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing benserazide and levodopa in oral dose form (medicinal product form)	Has active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing only benserazide and levodopa in oral dose form (medicinal product form)	Has active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa anhydrous (as carbidopa) 18.75 milligram and entacapone 200 milligram and levodopa 75 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	2
Product containing precisely carbidopa anhydrous (as carbidopa) 18.75 milligram and entacapone 200 milligram and levodopa 75 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	2
Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)	Has active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	2
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	2
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	False	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing carbidopa and levodopa in oromucosal dose form (medicinal product form)	Has active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	False	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	2
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet	Has basis of strength substance	True	Levodopa	Inferred relationship	Existential restriction modifier	2
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet	Has precise active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier	2
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd)	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Stalevo 50mg/12.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (DE Pharmaceuticals) 30 tablet	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Ethigen Ltd)	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Ethigen Ltd) 100 tablet	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Levodopa 125mg capsule	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Levodopa 250mg capsule	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Levodopa 500mg tablet - product	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Levodopa 500mg capsule	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Brocadopa 250mg capsule	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Brocadopa 125mg capsule	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Larodopa 500mg tablet	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Brocadopa 500mg capsule	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Product containing precisely levodopa 500 milligram/1 each conventional release oral tablet	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Mawdsley-Brooks & Company Ltd)	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Mawdsley-Brooks & Company Ltd) 100 tablet	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Pilsco Ltd) 50 tablet	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Pilsco Ltd)	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (Ethigen Ltd) 100 tablet	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Pilsco Ltd) 100 tablet	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (Ethigen Ltd)	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) 100 capsule	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (DE Pharmaceuticals) 90 tablet	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals)	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablets (DE Pharmaceuticals) 100 tablet	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablets (DE Pharmaceuticals)	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (DE Pharmaceuticals)	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/100mg tablets (DE Pharmaceuticals) 90 tablet	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Co-beneldopa 50mg/200mg capsules (DE Pharmaceuticals) 100 capsule	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Co-beneldopa 50mg/200mg capsules (DE Pharmaceuticals)	Has specific active ingredient	True	Levodopa	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/100mg m/r tablet	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 50mg/200mg m/r tablet	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 10mg/100mg tablet	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/100mg tablet	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablet	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Generic Stalevo 100mg/25mg/200mg tablets	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Generic Stalevo 150mg/37.5mg/200mg tablets	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 2.5mg/10mg/5ml oral suspension	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg/5ml oral suspension	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 10mg/100mg/5ml oral suspension	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg/5ml oral suspension	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 50mg/200mg/5ml oral suspension	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier
Co-careldopa 6.25mg/25mg/5ml oral suspension	Has active ingredient	False	Levodopa	Inferred relationship	Existential restriction modifier

Start Page 2 of 13 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461264012	Levodopa (substance)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
1481200014	Levodopa	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
1491864012	L-3-hydroxytyrosine	en	Synonym	Active	Entire term case sensitive	SNOMED CT core module
3766620018	L-dopa	en	Synonym	Active	Entire term case sensitive	SNOMED CT core module